NCT00579267

Brief Summary

The primary aims of this study are to assess:

  1. 1.The inter-rater and test-retest reliability of the MINI-KID
  2. 2.The validity of the standard MINI-KID interview in relation to the parent rated pencil/paper version (MINI-KID-P) and th longer clinician rated "Schedule for Affective Disorders and Schizophrenia for School Aged Children-Present and Lifetime Version (K-SADS-PL) and "expert opinion" (when available).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
230

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Feb 2004

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2004

Completed
3.9 years until next milestone

First Submitted

Initial submission to the registry

December 18, 2007

Completed
6 days until next milestone

First Posted

Study publicly available on registry

December 24, 2007

Completed
8 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2008

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2008

Completed
Last Updated

February 16, 2009

Status Verified

December 1, 2007

Enrollment Period

3.9 years

First QC Date

December 18, 2007

Last Update Submit

February 13, 2009

Conditions

Major DepressionManiaAnxiety DisordersPsychotic DisorderAlcohol DependenceDrug DependenceEating DisordersSuicidalityDysthymiaADHDTourettes DisorderConduct DisorderOppositional Defiant DisorderPervasive Developmental Disorder

Keywords

MINI-KIDstructured diagnostic interviewreliability and validityK-SADSSheehan Disability Scale

Outcome Measures

Primary Outcomes (1)

  • Kappa scores between MINI Kid and K-SADS

    4 years

Interventions

MINI-KIDOTHER

Structured Diagnostic Interview for children and adolescent psychiatric disorders.

Eligibility Criteria

Age6 Years - 17 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Children and adolescents between the ages of 6 and 18 years.

You may qualify if:

  • Subjects will be between the ages of 6 years and 17 years, 11 months
  • All subjects must meet MINI-KID DSM-IV criteria for a least one of the Axis I child psychiatry disorders covered by the MINI-KID.
  • Both sexes are included.

You may not qualify if:

  • Subjects who suffer from mental retardation, significant developmental disorders, congenital abnormalities, delirium, dementia, a language problem, or brain damage will be excluded.
  • Subjects with neurological disorders, chronic or life threatening diseases will be excluded.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of South Florida College of Medicine, Department of Psychiatry

Tampa, Florida, 33613-4788, United States

Location

Related Publications (1)

  • Sheehan DV, Sheehan KH, Shytle RD, Janavs J, Bannon Y, Rogers JE, Milo KM, Stock SL, Wilkinson B. Reliability and validity of the Mini International Neuropsychiatric Interview for Children and Adolescents (MINI-KID). J Clin Psychiatry. 2010 Mar;71(3):313-26. doi: 10.4088/JCP.09m05305whi.

    PMID: 20331933DERIVED

MeSH Terms

Conditions

Depressive Disorder, MajorManiaAnxiety DisordersPsychotic DisordersAlcoholismSubstance-Related DisordersFeeding and Eating DisordersSuicidal IdeationDysthymic DisorderAttention Deficit Disorder with HyperactivityTourette SyndromeConduct DisorderOppositional Defiant DisorderChild Development Disorders, Pervasive

Condition Hierarchy (Ancestors)

Depressive DisorderMood DisordersMental DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsSchizophrenia Spectrum and Other Psychotic DisordersAlcohol-Related DisordersChemically-Induced DisordersSigns and Symptoms, DigestiveSuicideSelf-Injurious BehaviorBehavioral SymptomsBehaviorAttention Deficit and Disruptive Behavior DisordersNeurodevelopmental DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesTic DisordersMovement DisordersHeredodegenerative Disorders, Nervous SystemNeurodegenerative DiseasesGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Officials

  • David V. Sheehan, MD, MBA

    University of South Florida College of Medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER

Study Record Dates

First Submitted

December 18, 2007

First Posted

December 24, 2007

Study Start

February 1, 2004

Primary Completion

January 1, 2008

Study Completion

January 1, 2008

Last Updated

February 16, 2009

Record last verified: 2007-12

Locations

US(1)